908 Devices (MASS) Cash from Operations Growth (1y) (2021 - 2026)
908 Devices (MASS) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 122.43% |
| 10 | 908 Devices | 260.31 Mn | 148.57 Mn | 6.88 Mn | 108.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.02% |
| Dec 31, 2025 | 158.81% |
| Sep 30, 2025 | 25.02% |
| Jun 30, 2025 | 55.64% |
| Mar 31, 2025 | -60.51% |
| Dec 31, 2024 | -16.22% |
| Sep 30, 2024 | -21.89% |
| Jun 30, 2024 | -65.44% |
| Mar 31, 2024 | 12.12% |
| Dec 31, 2023 | 62.28% |
| Sep 30, 2023 | 6.84% |
| Jun 30, 2023 | 24.28% |
| Mar 31, 2023 | -2,184.76% |
| Dec 31, 2022 | 44.51% |
| Sep 30, 2022 | -68.88% |
| Jun 30, 2022 | -42.51% |
| Mar 31, 2022 | 95.16% |
| Dec 31, 2021 | -495.37% |
| Sep 30, 2021 | -135.67% |
| Jun 30, 2021 | -126.16% |